Artificial Intelligence for Drug Discovery Market Booming at a 42% CAGR in 2019-2026

admin | December 12, 2019 | 1157 | Chemical & Material , Pharma

Spread the love

The global artificial intelligence for drug discovery market is expected to reach around US$ 8,149 Million by 2026 with a CAGR of above 42% during the forecast period 2019-2026.

Free Download Sample Report Pages for Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/1621

Artificial intelligence is gaining traction in the recent years. Continuous advancements in technology across the globe especially computer systems has resulted in development of various machines in order to solve complex tasks. Artificial intelligence is finding wide applicability in various industry verticals. Developing pharmaceutical sector in developed and developing countries and focus on development of new analytical approach for design and development of new novel products is resulting in adoption of artificial intelligence in development of various drugs. With the help of AI the highly complex and data intense process can be simplified. Artificial intelligence offers the facility to sort and postscript these libraries for targeted results and faster discovery.

The global Artificial Intelligence for Drug Discovery market is segmented into drug type, technology, application, end use, and region. The market in North America is expected to contribute a major revenue share. This can be attributed to well-developed healthcare infrastructure for R&D activities and increasing public-private partnerships for development of innovative drugs. In addition, rising manufacturers approach towards reducing the high cost associated to drug discovery is resulting in adoption of artificial intelligence which is another factor expected to support the growth of the target market in this region.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/artificial-intelligence-for-drug-discovery-market

The regional market is further segmented into North America, Europe, Asia Pacific, Latin America, and Middle East.

The market in Asia Pacific is expected to witness faster growth due to rapid technological advancements in the pharmaceutical sector. Rising presence of pharmaceutical manufacturers in the country such as China and India, developing government policies for drug development, along with rising awareness related to AI in various industry verticals are some other factors expected to further support the growth of the target market in this region.

Major factors expected to drive the growth of the global artificial intelligence in drug discovery market are growing awareness related to artificial intelligence in pharmaceutical sector, rising investment related to drug development in developed and developing countries, along with ability of AI to work in complex areas in biopharmaceutical science. In addition, increasing investment by major players in bioparma companies for development of new drugs is expected to further support the growth of the global market.  In 2019, GSK invested US$ 300 Mn in the gene testing company 23andMe. This will help the company to access vast DNA database, providing information about the relations between genes and diseases.

However, lack of government regulations related to AI and AI technological experts are major factors expected to hamper the growth of the global AI in drug discovery market. In addition, lack of infrastructure in developing countries for implementing artificial intelligence is another factor expected to challenge the growth of the target market.

Related Reports:

Increasing investment by major players for research and development activities and development of new products along with rising public private partnerships between regional and international players is expected to create new revenue opportunities for players operating in the global market over the forecast period. In addition, strategic business development activities in order to increase the customer base are expected to support the growth of the target market in terms of revenue.

The Artificial Intelligence for Drug Discovery market in segmented in to drug type, technology, application, end use. The drug type segment is bifurcated into small molecule and large molecule. The small molecule is expected to account for major revenue share due to high complicated process in drug discovery, coupled with AI helps solving complex process with accurate results and in less time.

Some of the major players operating in the global artificial intelligence for drug discovery market are Atomwise, Inc., Insilico Medicine, BIOAGE, Numerate, NuMedii, Inc., Envisagenics, Cloud Pharmaceuticals, Inc., BenevolentAI, twoXAR Incorporated, and Exscientia. The market players are focused on introduction of new innovative products and lower the operational cost associated to drug discovery.

Key Findings

The global Artificial Intelligence for Drug Discovery market was valued at around US$ 486 Bn in 2018. Among the drug type segment the small molecule segment is expected to contribute significant revenue shares in the market globally.

Request for Customization@ https://www.acumenresearchandconsulting.com/request-customization/1621

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report@ https://www.acumenresearchandconsulting.com/buy-now/0/1621

If you would like to place an order or have any questions, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157 OR +1 408 900 9135

For Latest Update Follow Us:

https://twitter.com/AcumenRC

https://www.facebook.com/acumenresearchandconsulting

https://www.linkedin.com/company/acumen-research-and-consulting/

Tags:

Related Posts

1,149 thoughts on “Artificial Intelligence for Drug Discovery Market Booming at a 42% CAGR in 2019-2026”

Leave a Reply

Your email address will not be published. Required fields are marked *

Acumen Research and Consulting

  • Esoteric Testing Market Will Touch US$ 40 Bn in 2026

    The worldwide Esoteric Testing Market is set to surpass US$ 40 billion by the year end of 2026 and growing at a CAGR of 10 % from 2019-2026. Several players, including Laboratory Corporation of America, BioMONTR and American Esoteric Laboratories (AEL), OPKO Health, Nordic Laboratories, Miraca Holdings, ACM, Fulgent Genetics, Genomic health, Invitae, Mayo Medical … Continue reading "Esoteric Testing Market Will Touch US$ 40 Bn in 2026"

  • End-of-Line Packaging Market Hit $6.4 Bn in 2026

    The worldwide End-of-Line Packaging Market is set to surpass US$ 6.4 billion by the year end of 2026 and growing at a CAGR of 4 % from 2019-2026. Several players, including Combi Packaging Systems LLC, DS Smith plc, Bosch Packaging Technology Krones AG, Mach Inc., Optima Packaging Group GmbH, Gebo Cermex, IMA S.p.A., Festo Corporation, … Continue reading "End-of-Line Packaging Market Hit $6.4 Bn in 2026"

  • Global Craniomaxillofacial (CMF) Devices Market Worth $3.5 Bn by 2026

    The worldwide Craniomaxillofacial (CMF) Devices Market is set to surpass US$ 3.5 billion by the year end of 2026 and growing at a CAGR of 5.7 % from 2019-2026. Several players, including DePuy Synthes (J&J), Medtronic, Stryker and Zimmer-Biomet, companies, research institutes, contract manufacturing organizations, and non-profit organizations, are playing a critical role in the … Continue reading "Global Craniomaxillofacial (CMF) Devices Market Worth $3.5 Bn by 2026"

  • Real-time PCR (qPCR) and Digital PCR (dPCR) Industry Reach US$ 4.2 billion by 2026

    According to Acumen Research and Consulting, the global Real-time PCR (qPCR) & Digital PCR (dPCR) market is expected to grow at noteworthy CAGR around 8.1 % throughout the forecast period and reach around US$ 4.2 billion by 2026. The report analyzes and forecasts the Real-time PCR (qPCR) and Digital PCR (dPCR) market at global and regional … Continue reading "Real-time PCR (qPCR) and Digital PCR (dPCR) Industry Reach US$ 4.2 billion by 2026"

  • Sports Medicine Industry Reach US$ 13 billion by 2026

    The global sports medicine market value is expected to reach around US$ 13 billion by 2026 and growing at a CAGR of 7% throughout the forecast period 2019-2026. The report analyzes and forecasts the Sports Medicine market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) … Continue reading "Sports Medicine Industry Reach US$ 13 billion by 2026"

  • Meningococcal Vaccines Industry Value is Estimated to Hit USD 9.37 billion by 2026

    The global meningococcal vaccines market value is estimated to hit USD 9.37 billion by 2026 and expected to grow at a CAGR of 12.3% over period 2019 to 2026. The report analyzes and forecasts the Meningococcal Vaccines market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ … Continue reading "Meningococcal Vaccines Industry Value is Estimated to Hit USD 9.37 billion by 2026"

  • Transcatheter Heart Valve Replacement Systems Industry Reach US$ 11 billion by 2019-2026

    According to Acumen Research and Consulting, the global transcatheter heart valve replacement market size is expected to reach around US$ 11 billion by 2026 with 12.9 % of CAGR throughout the forecast period 2019-2026. The report analyzes and forecasts the Transcatheter Heart Valve Replacement Systems market at global and regional levels. The market has been forecast … Continue reading "Transcatheter Heart Valve Replacement Systems Industry Reach US$ 11 billion by 2019-2026"

  • Coronary Stents Industry Size is Expected US$ 16.88 billion by 2025

    The global coronary stents market size is expected to worth around US$ 16.88 billion by 2025, and market is registering growth at 7% from 2018 to 2025. The report analyzes and forecasts the Coronary Stents market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from … Continue reading "Coronary Stents Industry Size is Expected US$ 16.88 billion by 2025"

  • Biosensors Industry Reach around US$ 32 billion by 2019-2026

    According to Acumen Research and Consulting, the global biosensors market is expected to grow at noteworthy CAGR around 7.8 % throughout the forecast period and reach around US$ 32 billion by 2026. The report analyzes and forecasts the Biosensors market at global and regional levels. The market has been forecast based on volume (Tons) and value … Continue reading "Biosensors Industry Reach around US$ 32 billion by 2019-2026"

  • Real-time PCR (qPCR) and Digital PCR (dPCR) Industry Reach US$ 4.2 billion by 2026

    According to Acumen Research and Consulting, the global Real-time PCR (qPCR) & Digital PCR (dPCR) market is expected to grow at noteworthy CAGR around 8.1 % throughout the forecast period and reach around US$ 4.2 billion by 2026. The report analyzes and forecasts the Real-time PCR (qPCR) and Digital PCR (dPCR) market at global and regional … Continue reading "Real-time PCR (qPCR) and Digital PCR (dPCR) Industry Reach US$ 4.2 billion by 2026"

Recent Posts